2015
Estrogen withdrawal, breast cell transformation, and multiple breast cancer risk in women with the KRAS-variant.
Weidhaas J, McVeigh T, Jung S, Salzman D, Nallur S, Dookwah M, Nemec A, Sadofsky J, Paranjape T, Kelly O, Chan E, Miller N, Sweeney K, Zelterman D, Sweasy J, Pilarski R, Telesca D, Kerin M. Estrogen withdrawal, breast cell transformation, and multiple breast cancer risk in women with the KRAS-variant. Journal Of Clinical Oncology 2015, 33: e12541-e12541. DOI: 10.1200/jco.2015.33.15_suppl.e12541.Peer-Reviewed Original Research
2012
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer
Pilarski R, Patel DA, Weitzel J, McVeigh T, Dorairaj JJ, Heneghan HM, Miller N, Weidhaas JB, Kerin MJ, McKenna M, Wu X, Hildebrandt M, Zelterman D, Sand S, Shulman LP. The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer. PLOS ONE 2012, 7: e37891. PMID: 22662244, PMCID: PMC3360659, DOI: 10.1371/journal.pone.0037891.Peer-Reviewed Original ResearchConceptsPrimary patientsOvarian cancer riskKRAS-variantOvarian cancer diagnosisOvarian cancerPrimary cancerFamily historyCancer diagnosisCancer riskTriple-negative breast cancerAdditional cancer diagnosesDouble primary breastTriple primary cancersPositive family historyAge of diagnosisNegative breast cancerDeleterious BRCA mutationsBreast primaryPathologic diagnosisBRCA mutationsPrimary breastBreast cancerHBOC familiesPatientsHereditary breast